These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26590894)

  • 1. Nanopolymersomes as potential carriers for rifampicin pulmonary delivery.
    Moretton MA; Cagel M; Bernabeu E; Gonzalez L; Chiappetta DA
    Colloids Surf B Biointerfaces; 2015 Dec; 136():1017-25. PubMed ID: 26590894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles.
    Moretton MA; Glisoni RJ; Chiappetta DA; Sosnik A
    Colloids Surf B Biointerfaces; 2010 Sep; 79(2):467-79. PubMed ID: 20627665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.
    Moretton MA; Hocht C; Taira C; Sosnik A
    Nanomedicine (Lond); 2014 Aug; 9(11):1635-50. PubMed ID: 24410279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2005 Oct; 26(4):298-303. PubMed ID: 16154726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis.
    Maretti E; Rossi T; Bondi M; Croce MA; Hanuskova M; Leo E; Sacchetti F; Iannuccelli V
    Int J Pharm; 2014 Feb; 462(1-2):74-82. PubMed ID: 24374224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs.
    Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A
    Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
    Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
    Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
    Xu W; Wei X; Wei K; Cao X; Zhong S
    Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
    Falamarzian A; Lavasanifar A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment.
    Khadka P; Dummer J; Hill PC; Das SC
    Int J Pharm; 2018 Sep; 548(1):244-254. PubMed ID: 29983396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.
    Carneiro SP; Carvalho KV; de Oliveira Aguiar Soares RD; Carneiro CM; de Andrade MHG; Duarte RS; Dos Santos ODH
    Colloids Surf B Biointerfaces; 2019 Mar; 175():306-313. PubMed ID: 30553206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A; Sharma S; Khuller GK
    J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs.
    Pandey R; Sharma S; Khuller GK
    Indian J Exp Biol; 2004 Jun; 42(6):562-6. PubMed ID: 15260105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolyzed galactomannan-modified nanoparticles and flower-like polymeric micelles for the active targeting of rifampicin to macrophages.
    Moretton MA; Chiappetta DA; Andrade F; das Neves J; Ferreira D; Sarmento B; Sosnik A
    J Biomed Nanotechnol; 2013 Jun; 9(6):1076-87. PubMed ID: 23858973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.